PAPER Lin F, Jia J, Qin W
SEARCH RESULTS
330986 RESULTS
PAPER El Melik R, Dubil A, Pound MW
Duration of therapy with acetylcholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease as reported in the literature.
Consult Pharm. 2014 Jun;29(6):400-7. PubMed: 25202893PAPER Bougea A, Gerakoulis S, Anagnostou E, Paraskevas G, Kapaki E, Kararizou E
Donepezil-induced myoclonus in a patient with Alzheimer disease.
Ann Pharmacother. 2014 Dec;48(12):1659-61. Epub 2014 Sep 8 PubMed: 25202036PAPER Zhu XC, Yu Y, Wang HF, Jiang T, Cao L, Wang C, Wang J, Tan CC, Meng XF, Tan L, Yu JT
Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis.
J Alzheimers Dis. 2015;44(1):163-74. PubMed: 25201787PAPER Jochemsen HM, van der Flier WM, Ashby EL, Teunissen CE, Jones RE, Wattjes MP, Scheltens P, Geerlings MI, Kehoe PG, Muller M
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.
J Alzheimers Dis. 2015;44(1):153-62. PubMed: 25201786PAPER Gironi M, Borgiani B, Farina E, Mariani E, Cursano C, Alberoni M, Nemni R, Comi G, Buscema M, Furlan R, Grossi E
A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process.
J Alzheimers Dis. 2015;43(4):1199-213. PubMed: 25201785PAPER Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H, Alzheimer Disease Neuroimaging Initiative, AddNeuroMed consortium, DESCRIPA and Kuopio L-MCI
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):79-92. PubMed: 25201784PAPER Bozzali M, Dowling C, Serra L, Spanò B, Torso M, Marra C, Castelli D, Dowell NG, Koch G, Caltagirone C, Cercignani M
The impact of cognitive reserve on brain functional connectivity in Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):243-50. PubMed: 25201783PAPER Suppa P, Anker U, Spies L, Bopp I, Rüegger-Frey B, Klaghofer R, Gocke C, Hampel H, Beck S, Buchert R
Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting.
J Alzheimers Dis. 2015;44(1):183-93. PubMed: 25201782PAPER Santangelo R, Coppi E, Ferrari L, Bernasconi MP, Pinto P, Passerini G, Comi G, Magnani G
Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
J Alzheimers Dis. 2015;43(4):1429-40. PubMed: 25201781PAPER Chang KL, Pee HN, Tan WP, Dawe GS, Holmes E, Nicholson JK, Chan EC, Ho PC
Metabolic profiling of CHO-AβPP695 cells revealed mitochondrial dysfunction prior to amyloid-β pathology and potential therapeutic effects of both PPARγ and PPARα Agonisms for Alzheimer's disease.
J Alzheimers Dis. 2015;44(1):215-31. PubMed: 25201780PAPER Eckerström C, Olsson E, Klasson N, Berge J, Nordlund A, Bjerke M, Wallin A
Multimodal prediction of dementia with up to 10 years follow up: the Gothenburg MCI study.
J Alzheimers Dis. 2015;44(1):205-14. PubMed: 25201779PAPER Goh LK, Lim WS, Teo S, Vijayaraghavan A, Chan M, Tay L, Ng TP, Tan CH, Lee TS, Chong MS
TOMM40 alterations in Alzheimer's disease over a 2-year follow-up period.
J Alzheimers Dis. 2015;44(1):57-61. PubMed: 25201778PAPER Lashley T, Gami P, Valizadeh N, Li A, Revesz T, Balazs R
Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease.
Neuropathol Appl Neurobiol. 2014 Sep 9; PubMed: 25201696PAPER Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC
Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
Lancet Neurol. 2014 Oct;13(10):997-1005. Epub 2014 Sep 4 PubMed: 25201514Current Filters
No filters selected